NZ shares fall on US fears of new outbreaks
New Zealand shares joined a global selloff as investor sentiment soured amid warnings that easing lockdowns could cause a second wave of covid-19 infections.
Wednesday, May 13th 2020, 5:56PM
by BusinessDesk
The S&P/NZX 50 Index slipped 30.64 points, or 0.3 percent, to 10,788.03. Within the index, 31 stocks fell and 19 rose. Turnover was $236.2 million.
Stock markets across Asia followed Wall Street lower after US infectious disease expert Anthony Fauci warned premature lifting of lockdowns could trigger new outbreaks of the deadly coronavirus, claiming more lives and further damaging economies, many of which have started to reopen.
New Zealand's benchmark index fell as much as 1.3 percent during the day, before regaining some ground as US futures began to turn upwards.
“Our market started off weaker, but we’ve actually picked up some momentum,” said Peter McIntyre, an investment adviser at Craigs Investment Partners.
“In the early stages today, US futures were in negative territory but have strengthened throughout the course of the day.”
SkyCity Entertainment Group led the market lower, falling 5.5 percent to $2.41, giving up the gains it made after the announcement New Zealand would move to alert level 2.
Fuel retailer Z Energy dropped 4.4 percent to $3.04 after it released weekly fuel volume data showing demand still down 42 percent compared to pre-lockdown levels. Refining NZ fell 4.6 percent to 83 cents.
The uncertain economic outlook drove investors away from Fletcher Building, which fell 4.5 percent to $3.20, ahead of a budget announcement that may include new infrastructure projects.
“Investors are looking for something in the budget for Fletcher, but the government has already made pledges on infrastructure so it’s a question of whether there will be anything new,” McIntyre said.
The day’s ‘risk-off mood’ saw some companies give up recent gains. Tourism Holdings fell 3.6 percent to $1.62, Kathmandu Holdings slipped 2.9 percent to 99 cents and Sky Network Television decreased 2.7 percent to 36 cents.
The NZX50 was buoyed by the Reserve Bank's decision to buy up $60 billion in government bonds, doubling its quantitative easing programme. It kept the official cash rate at 0.25 percent, but said it was prepared to use more tools if and when necessary.
That pushed the New Zealand dollar lower offering a boost to the NZX’s two biggest stocks, Fisher & Paykel Healthcare and A2 Milk. Both companies sell products in international markets and benefit from a weaker currency.
Fisher & Paykel Healthcare rose 3.3 percent to $31.00 and A2 Milk increased 1.3 percent to $19.55. Fonterra Shareholders' Fund units advanced 2.6 percent to $3.50.
Stock market operator NZX posted the day's biggest gain, up 3.9 percent at $1.35.
The dual-listed lenders were stronger, with Westpac Banking Corp up 1.3 percent at $16.39 and Australia & New Zealand Banking Group advancing 0.4 percent to $16.58. ASX-listed rival Commonwealth Bank of Australia today provided A$1.5 billion against potential losses from the covid-19 crisis, and sold a controlling stake in its Colonial First State funds management arm.
“The banks have been through the global financial crisis and their financial position is so much stronger than it was last time. They have spent a whole decade building up capital, so they are in good shape to withstand the shock from covid,” McIntyre said.
Outside the benchmark index, NZME fell 5.7 percent to 25 cents. The media group released its notice of meeting yesterday, which showed a shareholder resolution seeking to break up the company.
« Choppy trading on market but tide rises | Investors fear slow global recovery » |
Special Offers
Comments from our readers
No comments yet
Sign In to add your comment
Printable version | Email to a friend |